PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer

NCT04768608 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Castrate-Resistant Prostate Cancer

Interventions

DRUG: PD1-PSMA-CART cells

Sponsor

Zhejiang University

Collaborators

[object Object]